Worldwide Pharmacovigilance Industry 2019-2024: Accenture, IBM Corporation, Wipro, Cognizant, and Capgemini Hold Substantial Shares

NEXT STORY
Immuron CEO Dr. Gary S. Jacob to Present at the ThinkEquity Conference on May 2, 2019
PREV STORY
AB Science reports today its annual financials as of 31 December 2018 and provides an update on its activities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression

HALIFAX, Nova Scotia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

author_avatar
NASDAQ Market News

FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer

author_avatar
NASDAQ Market News

Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells

author_avatar
NASDAQ Market News